NYSE · CIK 0001156039
ELV Elevance Health, Inc.
Insider trading from SEC Form 4. Last filing Mar 5, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at Elevance Health, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 50Moderate | sell | Kendrick Charles Morgan JR EVP & President, Commercial | $3.2M | 7,417 | -47% | - |
Congressional trades
18 trades in ELV disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Alan Armstrong Senate · R-OK | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Markwayne Mullin Senate · R-OK | Purchase | ELV Elevance Health, Inc. Common Stock | $15k to $50k | Dec 29, 2025 | 18 days after the trade |
| Val T. Hoyle House · D-OR | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Oct 29, 2024 | 318 days after the trade |
| Val T. Hoyle House · D-OR | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Jan 13, 2025 | 242 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Aug 5, 2025 | 38 days after the trade |
| Lisa C. McClain House · R-MI | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Aug 13, 2025 | 30 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Jun 24, 2025 | 50 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Jul 10, 2025 | 34 days after the trade |
| Jefferson Shreve House · R-IN | Sale | ELV Elevance Health, Inc. Common Stock | $15k to $50k | May 12, 2025 | 41 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | May 30, 2025 | 7 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | ELV Elevance Health, Inc. Common Stock | $15k to $50k | May 15, 2025 | 16 days after the trade |
| Dan Newhouse House · R-WA | Partial sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Apr 11, 2025 | 35 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Apr 29, 2025 | 7 days after the trade |
| Jared Moskowitz House · D-FL | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Mar 10, 2025 | 29 days after the trade |
| Jared Moskowitz House · D-FL | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Mar 10, 2025 | 29 days after the trade |
| Jared Moskowitz House · D-FL | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Mar 10, 2025 | 29 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | ELV Elevance Health, Inc. Common Stock | $15k to $50k | Feb 24, 2025 | 13 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | ELV Elevance Health, Inc. Common Stock | $1,001 to $15k | Jan 13, 2025 | 31 days after the trade |
Transactions
The last 9 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | BOUDREAUX GAIL President and CEO | FTax withholding Common Stock | -10,396 | $395.50 | $4.1M | 116,313 | Mar 5, 2025 |
| Mar 3, 2025 | BOUDREAUX GAIL President and CEO | AGrant or award Common Stock | +10,620 | $0.00 | $0 | 126,933 | Mar 5, 2025 |
| Mar 3, 2025 | BOUDREAUX GAIL President and CEO | AGrant or award Common Stock | +15,587 | $0.00 | $0 | 142,520 | Mar 5, 2025 |
| Mar 3, 2025 | BOUDREAUX GAIL President and CEO | AGrant or award Employee Stock Option (Right to Buy)derivative | +40,429 | $0.00 | $0 | 40,429 | Mar 5, 2025 |
| Nov 1, 2024 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | FTax withholding Common Stock | -1,649 | $414.01 | $683k | 17,238 | Nov 5, 2024 |
| Nov 1, 2024 | Kendrick Charles Morgan JR EVP & President, Commercial | FTax withholding Common Stock | -846 | $414.01 | $350k | 7,577 | Nov 5, 2024 |
| Nov 1, 2024 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | AGrant or award Common Stock | +3,799 | $0.00 | $0 | 21,037 | Nov 5, 2024 |
| Nov 1, 2024 | Kendrick Charles Morgan JR EVP & President, Commercial | AGrant or award Common Stock | +1,710 | $0.00 | $0 | 9,287 | Nov 5, 2024 |
| Oct 18, 2024 | Kendrick Charles Morgan JR EVP & President, Commercial | SOpen-market sale Common Stock | -7,417 | $432.14 | $3.2M | 8,423 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- BOUDREAUX GAILPresident and CEO
- Haytaian Peter DEVP & Pres Carelon & CarelonRx
- Kendrick Charles Morgan JREVP & President, Commercial
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.